149 related articles for article (PubMed ID: 7923056)
1. Cytogenetics as a tool in the histologic subclassification of chondrosarcomas.
Dijkhuizen T; van den Berg E; Molenaar WM; Oosterhuis JW; Dam A; Wiersema J; Schraffordt Koops H; de Jong B
Cancer Genet Cytogenet; 1994 Sep; 76(2):100-5. PubMed ID: 7923056
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes.
Bovée JV; Sciot R; Dal Cin P; Debiec-Rychter M; van Zelderen-Bhola SL; Cornelisse CJ; Hogendoorn PC
Diagn Mol Pathol; 2001 Dec; 10(4):228-35. PubMed ID: 11763313
[TBL] [Abstract][Full Text] [Related]
3. [Comparative DNA cytometric and cytogenetic ploidy determination of chondrosarcoma and osteosarcoma].
Werner M; Rieck J; Heintz A; Pösl M; Delling G
Pathologe; 1996 Sep; 17(5):374-9. PubMed ID: 8992480
[TBL] [Abstract][Full Text] [Related]
4. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
6. [Histologic grading of chondrosarcoma. A qualitative and quantitative analysis of 74 cases of the Hamburg bone tumor register].
Welkerling H; Werner M; Delling G
Pathologe; 1996 Jan; 17(1):18-25. PubMed ID: 8685092
[TBL] [Abstract][Full Text] [Related]
7. Chondrosarcoma: biology, genetics, and epigenetics.
Chow WA
F1000Res; 2018; 7():. PubMed ID: 30519452
[TBL] [Abstract][Full Text] [Related]
8. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic findings in clear cell chondrosarcoma.
Nishio J; Reith JD; Ogose A; Maale G; Neff JR; Bridge JA
Cancer Genet Cytogenet; 2005 Oct; 162(1):74-7. PubMed ID: 16157204
[TBL] [Abstract][Full Text] [Related]
10. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.
Hallor KH; Staaf J; Bovée JV; Hogendoorn PC; Cleton-Jansen AM; Knuutila S; Savola S; Niini T; Brosjö O; Bauer HC; Vult von Steyern F; Jonsson K; Skorpil M; Mandahl N; Mertens F
Clin Cancer Res; 2009 Apr; 15(8):2685-94. PubMed ID: 19336518
[TBL] [Abstract][Full Text] [Related]
12. Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors?
Rubin BP; Fletcher JA
Adv Anat Pathol; 1999 Jul; 6(4):204-12. PubMed ID: 10410173
[TBL] [Abstract][Full Text] [Related]
13. Complex cytogenetic aberrations in a well-differentiated chondrosarcoma.
Fletcher JA; Lipinski KK; Weidner N; Morton CC
Cancer Genet Cytogenet; 1989 Aug; 41(1):115-21. PubMed ID: 2766246
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin.
Gil-Benso R; Lopez-Gines C; López-Guerrero JA; Carda C; Callaghan RC; Navarro S; Ferrer J; Pellín A; Llombart-Bosch A
Lab Invest; 2003 Jun; 83(6):877-87. PubMed ID: 12808123
[TBL] [Abstract][Full Text] [Related]
15. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
[TBL] [Abstract][Full Text] [Related]
16. [Overexpression of c-erbB-2 proto-oncogene product in chondrosarcomas].
Li N; Shen LH; Zhu QF
Zhonghua Bing Li Xue Za Zhi; 1994 Feb; 23(1):37-9. PubMed ID: 7913884
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic hybridization in cartilaginous tumors.
Ozaki T; Wai D; Schäfer KL; Lindner N; Böcker W; Winkelmann W; Dockhorn-Dworniczak B; Poremba C
Anticancer Res; 2004; 24(3a):1721-5. PubMed ID: 15274346
[TBL] [Abstract][Full Text] [Related]
18. Clonal chromosome abnormalities in enchondromas and chondrosarcomas.
Gunawan B; Weber M; Bergmann F; Wildberger J; Niethard FU; Füzesi L
Cancer Genet Cytogenet; 2000 Jul; 120(2):127-30. PubMed ID: 10942802
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic findings in 19 malignant bone tumors.
Ozisik YY; Meloni AM; Peier A; Altungoz O; Spanier SS; Zalupski MM; Leong SP; Sandberg AA
Cancer; 1994 Oct; 74(8):2268-75. PubMed ID: 7922978
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic aberrations and their prognostic impact in chondrosarcoma.
Mandahl N; Gustafson P; Mertens F; Akerman M; Baldetorp B; Gisselsson D; Knuutila S; Bauer HC; Larsson O
Genes Chromosomes Cancer; 2002 Feb; 33(2):188-200. PubMed ID: 11793445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
